Transscleral Nd: YAG laser cyclophotocoagulation versus cyclocryotherapy.

Y Suzuki, M Araie, A Yumita, T Yamamoto
Author Information
  1. Y Suzuki: Department of Ophthalmology, Faculty of Medicine, University of Tokyo, Japan.

Abstract

The post-operative course of intraocular pressure (IOP) after transscleral Nd: YAG laser cyclophotocoagulation (TSYLC) in refractory glaucoma was studied using the life-table method and retrospectively compared with that of cyclocryotherapy. In all, 36 eyes of 36 patients who underwent TSYLC for the first time and 80 eyes of 75 patients who underwent cyclocryotherapy for the first time were included in the present study. The follow-up averaged 9.2 months (range, 1-21 months) in patients receiving cyclocryotherapy. In patients with a preoperative visual acuity of greater than or equal to 0.01, the successful control of IOP was represented by a value of less than 21 mmHg that was obtained without additional medication, and that in patients who had a visual acuity of less than 0.01 was represented by a decrease in IOP of at least 25%, also obtained without additional medication. The success rate of the TSYLC-treated group at 21 months after treatment was 45.2% +/- 11.7%, whereas that of the group receiving cyclocryotherapy was 38.9% +/- 6.1%. The difference between these success rates was not statistically significant (P greater than 0.05). Complications such as phthisis bulbi, hypotony, hemorrhage in the anterior chamber or swelling of the eyelids were less frequent in the TSYLC-treated group than in the group given cyclocryotherapy. TSYLC is thought to be as effective as cyclocryotherapy in lowering IOP, but with fewer complications.

References

  1. Ophthalmology. 1987 Dec;94(12):1519-22 [PMID: 3431821]
  2. Surv Ophthalmol. 1983 Sep-Oct;28(2):93-100 [PMID: 6359516]
  3. Arch Ophthalmol. 1973 Jul;90(1):27-8 [PMID: 4736646]
  4. Am J Ophthalmol. 1972 Nov;74(5):862-7 [PMID: 4674813]
  5. Ophthalmic Surg. 1985 Feb;16(2):95-8 [PMID: 4039809]
  6. Invest Ophthalmol Vis Sci. 1989 Aug;30(8):1834-7 [PMID: 2759796]
  7. Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol. 1977 Jan-Feb;83(1):90-113 [PMID: 898479]
  8. Am J Ophthalmol. 1978 Jul;86(1):24-6 [PMID: 677228]
  9. Jpn J Ophthalmol. 1982;26(4):361-73 [PMID: 7166896]
  10. J Am Med Assoc. 1950 Mar 25;142(12):889-97 [PMID: 15405993]
  11. Graefes Arch Clin Exp Ophthalmol. 1989;227(2):172-9 [PMID: 2470656]
  12. Am J Ophthalmol. 1984 Sep 15;98(3):271-82 [PMID: 6383055]
  13. Am J Ophthalmol. 1967 Oct;64(4):700-7 [PMID: 6061525]
  14. Ophthalmology. 1985 Jul;92(7):947-54 [PMID: 2410846]
  15. Am J Ophthalmol. 1976 Nov;82(5):722-32 [PMID: 826160]
  16. Ophthalmology. 1988 Jun;95(6):719-22 [PMID: 3211471]
  17. Arch Ophthalmol. 1977 Feb;95(2):285-8 [PMID: 402130]

MeSH Term

Adolescent
Adult
Aged
Aged, 80 and over
Child
Ciliary Body
Cryosurgery
Follow-Up Studies
Glaucoma
Humans
Intraocular Pressure
Life Tables
Light Coagulation
Middle Aged
Postoperative Care
Postoperative Complications
Retrospective Studies
Sclera
Visual Acuity

Word Cloud

Created with Highcharts 10.0.0cyclocryotherapypatientsIOPgroupTSYLCmonths0lessNd:YAGlasercyclophotocoagulation36eyesunderwentfirsttimereceivingvisualacuitygreater01represented21obtainedwithoutadditionalmedicationsuccessTSYLC-treated+/-post-operativecourseintraocularpressuretransscleralrefractoryglaucomastudiedusinglife-tablemethodretrospectivelycompared8075includedpresentstudyfollow-upaveraged92range1-21preoperativeequalsuccessfulcontrolvaluemmHgdecreaseleast25%alsoratetreatment452%117%whereas389%61%differenceratesstatisticallysignificantP05ComplicationsphthisisbulbihypotonyhemorrhageanteriorchamberswellingeyelidsfrequentgiventhoughteffectiveloweringfewercomplicationsTransscleralversus

Similar Articles

Cited By